Skip navigation

Leverage Technologies and Innovation to Deliver Accurate Patient Data to Ensure Greater Efficiencies in Clinical Trials and Regulatory Submissions

December 13-15, 2016
  • Philadelphia, PA

eCOA / ePRO 2016 — Utilizing mobile devices, sensors, wearable devices and other innovative technologies in clinical trial data collection may help provide more accurate clinical reporting by patients, minimize costs for sponsors and ultimately allow greater patient participation from remote locations, making trials more efficient. These benefits however come with challenges — from the design, implementation, execution and regulatory standpoint.

Our agenda delivers cutting-edge content focused on how to leverage the latest innovations in eCOA/ePRO as part of a clinical trial strategy. Don’t miss this educational opportunity with peers in the healthcare sector to hear real-world case studies and lessons learned about recent and current eCOA/ePRO trials from Pfizer Inc, Johns Hopkins University, Mayo Clinic, Trigemina, YPrime, Zosano Pharma and others!

CONFERENCE CO-CHAIRS

CBI’s esteemed faculty share successful eCOA/ePRO strategies, explore eCOA/ePRO implementation lessons learned and deliver real-word case studies to illustrate the latest innovations in clinical trials.

Joseph C. Cappelleri,
PhD, MPH, MS
Senior Director, Biostatistics
Pfizer Inc

Sheryl Pease, MBA, PMP
Patient-Centered Outcomes
Assessment Lead
Pfizer Inc

FEATURED SESSIONS

  • Technology and Measurement —
    Creating a New Future for Clinical Outcome Assessments
  • Bring Your Own Device (BYOD) Lessons Learned and Implementation Strategies
  • Regulatory Update on Recent FDA Guidance
  • Data Standardization —
    Exploring the “What?” “Who?” and “How?” to Prepare eData for the FDA
  • Streamline eCOA/ePRO Data Monitoring Processes
  • Study Execution and Operationalization of eCOAs
  • Utilize eCOA to Support Increased Quality of Life (QoL) Measurements
  • Case Study on eCOA Design and Implementation —
    Considerations for Migraine Indication

PREVIOUS ATTENDEE ACCLAIM:

High quality, inspiring and insightful conference that pinpoints important topics in the field of eCOA.

HEOR Scientist, Astrazeneca

An informative and engaging conference that not only highlighted the many facets of the featured topic but also explored other pertinent industry related issues.

LV Research Analyst, Corporate Translations

December 13-14, 2016 DoubleTree by Hilton Philadelphia, PA

eCOA / ePRO — Electronic Clinical Outcome Assessment and Electronic Patient Reported Outcome Summit

Leverage Technologies and Innovation to Deliver Accurate Patient Data to Ensure Greater Efficiencies in Clinical Trials and Regulatory Submissions

eCOA / ePRO 2016 — Utilizing mobile devices, sensors, wearable devices and other innovative technologies in clinical trial data collection may help provide more accurate clinical reporting by patients, minimize costs for sponsors and ultimately allow greater patient participation from remote locations, making trials more efficient. These benefits however come with challenges — from the design, implementation, execution and regulatory standpoint.

Our agenda delivers cutting-edge content focused on how to leverage the latest innovations in eCOA/ePRO as part of a clinical trial strategy. Don’t miss this educational opportunity with peers in the healthcare sector to hear real-world case studies and lessons learned about recent and current eCOA/ePRO trials from Pfizer Inc, Johns Hopkins University, Mayo Clinic, Trigemina, YPrime, Zosano Pharma and others!

CONFERENCE CO-CHAIRS

CBI’s esteemed faculty share successful eCOA/ePRO strategies, explore eCOA/ePRO implementation lessons learned and deliver real-word case studies to illustrate the latest innovations in clinical trials.

Joseph C. Cappelleri,
PhD, MPH, MS
Senior Director, Biostatistics
Pfizer Inc

Sheryl Pease, MBA, PMP
Patient-Centered Outcomes
Assessment Lead
Pfizer Inc

FEATURED SESSIONS

  • Technology and Measurement —
    Creating a New Future for Clinical Outcome Assessments
  • Bring Your Own Device (BYOD) Lessons Learned and Implementation Strategies
  • Regulatory Update on Recent FDA Guidance
  • Data Standardization —
    Exploring the “What?” “Who?” and “How?” to Prepare eData for the FDA
  • Streamline eCOA/ePRO Data Monitoring Processes
  • Study Execution and Operationalization of eCOAs
  • Utilize eCOA to Support Increased Quality of Life (QoL) Measurements
  • Case Study on eCOA Design and Implementation —
    Considerations for Migraine Indication

PREVIOUS ATTENDEE ACCLAIM:

High quality, inspiring and insightful conference that pinpoints important topics in the field of eCOA.

HEOR Scientist, Astrazeneca

An informative and engaging conference that not only highlighted the many facets of the featured topic but also explored other pertinent industry related issues.

LV Research Analyst, Corporate Translations

December 13-14, 2016 DoubleTree by Hilton Philadelphia, PA